NYSE American - Delayed Quote USD
Serina Therapeutics, Inc. (SER)
6.00
+0.22
+(3.81%)
As of 12:47:21 PM EDT. Market Open.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-17,137
-17,137
-2,476
-2,075.62
-2,250.78
Investing Cash Flow
-22
-22
-504
980.94
823.32
Financing Cash Flow
13,212
13,212
10,067
1,312.07
1,077.25
End Cash Position
3,672
3,672
7,619
532.23
314.85
Interest Paid Supplemental Data
--
--
--
15.88
3.09
Capital Expenditure
-22
-22
-504
-9.68
-108.43
Issuance of Capital Stock
5,000
5,000
--
4.42
90.15
Issuance of Debt
3,043
3,043
10,100
5,000
--
Repayment of Debt
-168
-168
-48
-3,692.35
-12.91
Free Cash Flow
-17,159
-17,159
-2,980
-2,085.31
-2,359.21
12/31/2021 - 11/29/2018
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
MOLN Molecular Partners AG
4.1500
-0.48%
NEXI NexImmune, Inc.
0.0001
0.00%
PYPD PolyPid Ltd.
2.6700
-2.91%
ADIL Adial Pharmaceuticals, Inc.
0.7010
-3.84%
LCTX Lineage Cell Therapeutics, Inc.
0.4743
+0.49%
BT3.BE Lineage Cell Therapeutics Inc
0.4020
+8.06%
NXOA.BE Nicox SA
0.2260
0.00%
HQ1.MU Oruka Therapeutics Inc. R
9.15
+0.55%
HTD.MU Corcept Therapeutics Inc
60.20
+5.73%
TNFA TNF Pharmaceuticals, Inc.
0.1848
-1.75%